Verbascoside

Pharmacology & Research

Verbascoside — more often called acteoside in the pharmacology literature — is a caffeoyl phenylethanoid glycoside: a caffeic-acid ester linked through a rhamnose–glucose sugar to a hydroxytyrosol (dihydroxyphenylethanol) unit. It is one of the most widespread phenolics in the plant kingdom, and in this database it turns up across unrelated families — mullein, rehmannia, catnip, dagga, warrior’s plume and pau d’arco — as one of the more abundant single constituents. Its two catechol (dihydroxyphenyl) groups make it a powerful radical scavenger and metal chelator, and isolated verbascoside shows anti-inflammatory, neuroprotective, anti-fatigue and cytostatic activity across cell and rodent models ^{1Reference 1Xiao Y et al. · 2022ReviewThe pharmacokinetic property and pharmacological activity of acteoside: A review — reviewView study →2Reference 2Alipieva K et al. · 2014ReviewVerbascoside — a review of its occurrence, (bio)synthesis and pharmacological significance — reviewView study →}. The caveat runs through all of it and reframes the rest of this page: verbascoside’s absolute oral bioavailability is roughly 0.12% in rats because intestinal bacteria hydrolyse the glycoside before it can be absorbed ^{1Reference 1Xiao Y et al. · 2022ReviewThe pharmacokinetic property and pharmacological activity of acteoside: A review — reviewView study →}. Intact verbascoside barely reaches the circulation, so a potent in-vitro concentration is not something an oral dose reaches systemically, and no effect here has been tested as the isolated molecule in a human trial.

1. Anti-inflammatory

The deepest and best-mechanised signal. Isolated verbascoside suppressed inducible nitric-oxide synthase (iNOS) and NF-κB signalling and lowered nitric-oxide output in human THP-1 monocytes ^{3Reference 3Speranza L et al. · 2010In vitroAntiinflammatory effects in THP-1 cells treated with verbascoside — in vitro (human monocytes)View study →}. Separately, verbascoside is a direct inhibitor of calcineurin — the Ca²⁺/calmodulin-dependent phosphatase that drives T-cell activation — inhibiting the enzyme in both calmodulin-activated and basal states, a specific molecular rationale for the traditional anti-inflammatory use of the plants that carry it ^{4Reference 4Prescott TAK et al. · 2011In vitroDirect inhibition of calcineurin by caffeoyl phenylethanoid glycosides from Teucrium chamaedrys and Nepeta cataria — in vitro / enzyme assayView study →}. In a taheebo (pau d’arco) polyphenol preparation, verbascoside was identified as the principal COX-2-selective component, binding the COX-2 catalytic site ^{5Reference 5Ma S et al. · 2017In vitroTaheebo Polyphenols Attenuate Free Fatty Acid-Induced Inflammation in Murine and Human Macrophage Cell Lines As Inhibitor of Cyclooxygenase-2 — in vitroView study →}; its broad anti-inflammatory pharmacology is catalogued in the dedicated review ^{2Reference 2Alipieva K et al. · 2014ReviewVerbascoside — a review of its occurrence, (bio)synthesis and pharmacological significance — reviewView study →}.

Gap: all cell-based or cell-free (human monocytes, isolated enzyme, a polyphenol mixture for the COX-2 work); no in-vivo anti-inflammatory dosing as the pure molecule and no human data, and systemic exposure is capped by the ~0.12% bioavailability.

2. Neuroprotection

The most interesting signal for a poorly absorbed molecule. In a chronic-stress mouse model of depression, a Lilii bulbus–Rehmannia co-decoction and its isolated key ingredient verbascoside, given orally, reduced neuroinflammation and intestinal permeability and improved depression-like behaviour by remodelling the gut microbiota–brain axis ^{6Reference 6Mao Q et al. · 2024AnimalCo-decoction of Lilii bulbus and Radix Rehmannia Recens and its key bioactive ingredient verbascoside inhibit neuroinflammation and intestinal permeability associated with chronic stress-induced depression via the gut microbiota-brain axis — mouse modelView study →}. Because the effect is framed through gut-barrier and microbiota changes rather than intact circulating verbascoside, it is mechanistically coherent despite the compound’s poor systemic absorption. Broader neuroprotective activity (antioxidant, anti-apoptotic) is reviewed at the class level ^{1Reference 1Xiao Y et al. · 2022ReviewThe pharmacokinetic property and pharmacological activity of acteoside: A review — reviewView study →2Reference 2Alipieva K et al. · 2014ReviewVerbascoside — a review of its occurrence, (bio)synthesis and pharmacological significance — reviewView study →}.

Gap: the pivotal in-vivo work pairs an isolated dose with a whole co-decoction, so the isolated-molecule contribution is not cleanly separable; rodent only, no human cognitive or mood data.

3. Antioxidant

Verbascoside’s signature chemistry. Isolated phenylethanoid glycosides including verbascoside are potent scavengers of superoxide anion and hydroxyl radical by spin-trapping assay, with activity tracking the number of phenolic hydroxyls ^{7Reference 7Wang P et al. · 1996In vitroScavenging effects of phenylpropanoid glycosides from Pedicularis on superoxide anion and hydroxyl radical by the spin trapping method — in vitroView study →}, and are strong Fe²⁺ chelators — the isomer isoverbascoside is roughly twice as active in chelation as verbascoside itself ^{8Reference 8Li J et al. · 1997In vitroAntioxidative and chelating activities of phenylpropanoid glycosides from Pedicularis striata — in vitroView study →}. This catechol-driven antioxidant capacity is the mechanism most often invoked to explain the compound’s downstream anti-inflammatory and cytoprotective effects ^{2Reference 2Alipieva K et al. · 2014ReviewVerbascoside — a review of its occurrence, (bio)synthesis and pharmacological significance — reviewView study →}.

Gap: the strongest data are cell-free chemistry (spin-trapping, chelation assays) — the most direct evidence but the least translatable, since a chemical radical-scavenging result in a cuvette says nothing about antioxidant activity from a barely-absorbed oral dose in a living animal.

4. Anti-fatigue

A small, coherent niche. Isolated verbascoside retarded skeletal-muscle fatigue at 20 µM in vitro ^{9Reference 9Liao F et al. · 1999In vitroRetardation of skeletal muscle fatigue by the two phenylpropanoid glycosides verbascoside and martynoside from Pedicularis plicata — in vitroView study →}, and in rodents it prolonged exercise endurance about as effectively as caffeine while lowering exercise-induced central 5-HT (serotonin) — a central rather than peripheral anti-fatigue mechanism ^{10Reference 10Zhu M et al. · 2016AnimalCentral anti-fatigue activity of verbascoside — rodent in vivo animal modelView study →}. Both findings come from the phenylethanoid-glycoside work on Pedicularis species, where verbascoside is the dominant active.

Gap: a handful of studies from a few groups; the in-vivo endurance data are rodent, and there is no human ergogenic trial.

5. Anticancer

The thinnest signal. Isolated verbascoside inhibited telomerase activity, shortened telomeres and induced G2/M cell-cycle arrest in MKN45 human gastric-cancer cells in vitro at ~17.8 µg/mL ^{11Reference 11Zhang F et al. · 2002In vitroIn vitro modulation of telomerase activity, telomere length and cell cycle in MKN45 cells by verbascoside — in vitroView study →}. The dedicated review lists similar cytostatic/pro-apoptotic activity in scattered other lines ^{2Reference 2Alipieva K et al. · 2014ReviewVerbascoside — a review of its occurrence, (bio)synthesis and pharmacological significance — reviewView study →}.

Gap: essentially a single in-vitro cell line at a concentration the poor oral bioavailability makes hard to reach systemically; no in-vivo tumour work here and no human oncology data.

Mechanisms

Target / pathway	Effect	Relevant to
NF-κB / iNOS	Suppresses → ↓nitric oxide, ↓pro-inflammatory cytokines	Anti-inflammatory
Calcineurin	Directly inhibits (Ca²⁺/calmodulin phosphatase) → ↓T-cell activation	Anti-inflammatory / immune
COX-2	Binds catalytic site → ↓prostaglandins (in polyphenol mixture)	Anti-inflammatory
Superoxide / hydroxyl radicals, Fe²⁺	Scavenges / chelates (catechol groups)	Antioxidant
Gut microbiota–brain axis	Restores intestinal barrier, ↓neuroinflammation	Neuroprotection
Central 5-HT	Lowers exercise-induced central serotonin	Anti-fatigue
Telomerase, cell cycle (G2/M)	Inhibits / arrests	Anticancer

Pharmacokinetics

Bioavailability is the load-bearing fact for the entire verbascoside literature. After oral dosing in rats the absolute oral bioavailability is only about 0.12%: the compound is absorbed and cleared quickly (peak plasma concentration within roughly 15 minutes), binds plasma protein at ~75%, and — critically — is extensively hydrolysed by intestinal bacteria before absorption, cleaving to its building blocks hydroxytyrosol and caffeic acid plus further degradation products ^{1Reference 1Xiao Y et al. · 2022ReviewThe pharmacokinetic property and pharmacological activity of acteoside: A review — reviewView study →}. This means the intact glycoside barely reaches the systemic circulation, and much of any oral effect is more plausibly attributable to its gut metabolites or to luminal/gut-axis action than to circulating verbascoside — which is exactly why the coherent in-vivo signal on this page (the antidepressant work) is framed through the gut-microbiota–brain axis ^{6Reference 6Mao Q et al. · 2024AnimalCo-decoction of Lilii bulbus and Radix Rehmannia Recens and its key bioactive ingredient verbascoside inhibit neuroinflammation and intestinal permeability associated with chronic stress-induced depression via the gut microbiota-brain axis — mouse modelView study →}. On the interaction side the news is reassuring: in human in-vitro systems verbascoside showed only weak inhibition of CYP1A2 and CYP1B1 (IC₅₀ ~83–86 µM), no CYP-mediated oxidative metabolism, and instead extensive Phase-II conjugation (methylation and sulfation), leading the authors to conclude it has no clinically relevant CYP-mediated interaction potential ^{12Reference 12Reid AM et al. · 2019In vitroIn Vitro Human Metabolism and Inhibition Potency of Verbascoside for CYP Enzymes — in vitroView study →}. The practical upshot: potent in-vitro concentrations are not trivially reachable from an oral dose, which tempers every downstream claim.

Clinical trials

There are essentially no registered trials of isolated verbascoside; human exposure is limited to verbascoside-rich foods and extracts (olive leaf, Cistanche, the herbs above), which are plant-matrix exposures and cannot be read as a molecule result. Everything on this page is in vitro or preclinical.

Last checked: July 2026.

Toxicity & Safety

Verbascoside carries a low toxicity flag. As a normal constituent of foods such as olives and olive leaf, and of many widely used herbs, it is regarded as having low toxicity at dietary levels, and reviews describe no signature acute organ toxicity in the animal studies performed with it ^{1Reference 1Xiao Y et al. · 2022ReviewThe pharmacokinetic property and pharmacological activity of acteoside: A review — reviewView study →}. Its interaction profile is favourable rather than worrying: in human in-vitro systems it inhibits CYP enzymes only weakly (CYP1A2/CYP1B1, high-micromolar IC₅₀), is not oxidatively metabolised by CYPs, and clears mainly through Phase-II conjugation, so it is judged to have no clinically relevant CYP-mediated drug-interaction potential ^{12Reference 12Reid AM et al. · 2019In vitroIn Vitro Human Metabolism and Inhibition Potency of Verbascoside for CYP Enzymes — in vitroView study →}. The one direct developmental-toxicity datapoint here is at the whole-extract level, not the isolated molecule: a Leonotis nepetifolia flower extract (which contains verbascoside among many constituents) was assessed for toxicity in zebrafish embryos ^{13Reference 13Adolpho L et al. · 2026Comprehensive analysis of Leonotis nepetifolia flower extracts: phytochemical composition and toxicity in zebrafish embryos — phytochemical / zebrafish embryoView study →} — a whole-plant result that cannot be read as a verbascoside finding. No dedicated human safety database exists for isolated, high-dose verbascoside, so absence of reported harm should not be read as established safety at supra-dietary doses.

Dosage

There is no established human dose for isolated verbascoside, and its poor oral bioavailability makes any extrapolation speculative. Preclinical work spans a wide range: rodent studies commonly use oral doses in the tens of milligrams per kilogram, and in-vitro effects appear at low-to-mid micromolar concentrations (e.g. muscle-fatigue retardation at 20 µM ^{9Reference 9Liao F et al. · 1999In vitroRetardation of skeletal muscle fatigue by the two phenylpropanoid glycosides verbascoside and martynoside from Pedicularis plicata — in vitroView study →}, gastric-cell cytostasis around 17.8 µg/mL ^{11Reference 11Zhang F et al. · 2002In vitroIn vitro modulation of telomerase activity, telomere length and cell cycle in MKN45 cells by verbascoside — in vitroView study →}) — figures that the ~0.12% oral bioavailability ^{1Reference 1Xiao Y et al. · 2022ReviewThe pharmacokinetic property and pharmacological activity of acteoside: A review — reviewView study →} makes hard to reach in a living animal from an oral dose. These are doses studied in research and are not a personal recommendation.

References